💥 Gate Square Event: #PTB Creative Contest# 💥
Post original content related to PTB, CandyDrop #77, or Launchpool on Gate Square for a chance to share 5,000 PTB rewards!
CandyDrop x PTB 👉 https://www.gate.com/zh/announcements/article/46922
PTB Launchpool is live 👉 https://www.gate.com/zh/announcements/article/46934
📅 Event Period: Sep 10, 2025 04:00 UTC – Sep 14, 2025 16:00 UTC
📌 How to Participate:
Post original content related to PTB, CandyDrop, or Launchpool
Minimum 80 words
Add hashtag: #PTB Creative Contest#
Include CandyDrop or Launchpool participation screenshot
🏆 Rewards:
🥇 1st
The German giant company announced that it has added Bitcoin (BTC) to its balance sheet!
Germany-based biopharmaceutical company ATAI Life Sciences announced its decision to allocate a portion of its treasury reserves to BTC, following in the footsteps of firms that have embraced Bitcoin as a strategic asset.
ATAI Life Sciences Chairman Christian Angermayer referred to the potential role of Bitcoin in capital preservation and optimization, explaining this move in a Substack post:
"In an era of persistent inflation and volatile markets, I find myself asking an important question for biotechnology companies that want to preserve and optimize their capital: Could allocating a portion of treasury cash to Bitcoin help a company preserve its capital, optimize it, and even extend its maturity, thereby contributing to its success?"
As part of its Bitcoin treasury strategy, ATAI Life Sciences will make an initial investment of 5 million dollars in BTC while maintaining sufficient cash reserves, short-term securities, and public equity to cover operational expenses until 2027.
The company's decision aligns with a growing trend among companies looking to diversify their treasury assets by including Bitcoin. This approach was popularized by MicroStrategy, where co-founder and CEO Michael Saylor is a vocal advocate for the adoption of institutional Bitcoin.